Clinical Trial Detail

NCT ID NCT01533948
Title Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed By Surgery
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

melanoma

Therapies

Axitinib

Age Groups: adult senior

No variant requirements are available.